-+ 0.00%
-+ 0.00%
-+ 0.00%

Benchmark Maintains Buy on BlueLinx Hldgs, Lowers Price Target to $120

Benzinga·02/21/2025 16:44:16
Listen to the news
Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and lowers the price target from $135 to $120.